NCT01556867

Brief Summary

At birth, the umbilical cord is cut, separating physically and symbolically the mother of his child. Before cord drop, umbilical area is a possible way of bacterial infection. Thus, umbilical cord infections constitute a major cause of neonatal morbidity and mortality in developing countries. In industrialized countries, omphalitis cases have almost disappeared whatever cord care strategies. At this day, care practices appear extremely different between countries, based more on habits and convictions that on evidence-based medicine. The investigators propose to conduct a non inferiority multicenter clustered crossed randomized study. Observations sessions will be performed on two consecutive periods of 5 months: 4 months of recruitment and 1 month follow-up. Main objective is to demonstrate that dry cord care practice would not expose to a higher risk of omphalitis than antiseptic based care approach. The purpose of NEOCORD study is a simplification of cord care for paramedical teams and parents, but also a significant reduction of costs in a medico-economic approach.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,698

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2011

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2012

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 16, 2012

Completed
Last Updated

August 8, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

February 17, 2012

Last Update Submit

August 5, 2016

Conditions

Keywords

Umbilical cord caredry cord careantisepticOmphalitisumbilical cord drophospitalized in maternity hospital

Outcome Measures

Primary Outcomes (1)

  • The incidence of occurrence of omphalitis within 28 days post-birth in omphalitis incidence in healthy newborn

    The primary endpoint will correspond to the incidence of omphalitis occurred within 28 days post-birth. The omphalitis is defined as the presence of erythema or serous or purulent in-cord tissue or umbilical perished. The stages are described to investigators about watching information in a search for suspected omphalitis. This can be confirmed retrospectively by an Awards Committee composed of a Dermatopédiatre, a pediatrician and a pediatric surgeon.

    13 months

Secondary Outcomes (8)

  • Occurrence of neonatal infection defined as any situation requiring hospitalization and antibiotics in the first month of life

    13 months

  • Date of the fall of the umbilical cord

    13 months

  • Description of bacterial flora in umbilical waning of omphalitis

    13 months

  • Parental satisfaction

    13 months

  • Occurrence of an infection or néonatlale maternal postpartum

    13 months

  • +3 more secondary outcomes

Study Arms (2)

dry cord care

ACTIVE COMPARATOR
Other: Cord care by simple debridement (soaping, rinsing and drying)

antiseptic care

ACTIVE COMPARATOR
Other: Cord care with the use of antiseptics

Interventions

For children born during an experimental period of cord care will be done with a simple debridement (soaping and then rinsing and drying carefully)

dry cord care

For children born during a control period, cord care will be done with an antiseptic whose choice is left to the discretion of the healthcare team. In this essay, it opted not to impose an antiseptic. Indeed, the objective of the trial is to compare the two strategies for management of care.

antiseptic care

Eligibility Criteria

Age1 Minute - 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Newborn \> 36 weeks of gestation.
  • Asymptomatic newborn hospitalization.
  • Information and consent of parental or legal authority.

You may not qualify if:

  • Outborn.
  • Family or social environment considered incompatible with dry cord care by investigator from a hygienic point of view (no fixed abode etc…).
  • Hospitalization in neonatal intensive care unit.
  • Transfer to another maternity hospital.
  • Gestational age less than or equal to 36 weeks of gestation.
  • Serious Congenital Pathology.
  • Opposition of parents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Dr SAVAGNER Christophe

Angers, France

Location

Dr GREMMO-FREGER Gisèle

Brest, France

Location

Dr GRAS-LEGUEN

Nantes, France

Location

Dr DESCOMBES-BARROSO Emmanuelle

Poitiers, France

Location

Pr PLADYS Patrick

Rennes, France

Location

Pr SALIBA Elie

Tours, France

Location

Related Publications (1)

  • Gras-Le Guen C, Caille A, Launay E, Boscher C, Godon N, Savagner C, Descombes E, Gremmo-Feger G, Pladys P, Saillant D, Legrand A, Caillon J, Barbarot S, Roze JC, Giraudeau B. Dry Care Versus Antiseptics for Umbilical Cord Care: A Cluster Randomized Trial. Pediatrics. 2017 Jan;139(1):e20161857. doi: 10.1542/peds.2016-1857.

MeSH Terms

Interventions

Desiccation

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Officials

  • Christèle GRAS-LE GUEN, PH

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR
  • Christophe SAVAGNER, PH

    University Hospital, Angers

    PRINCIPAL INVESTIGATOR
  • Patrick PLADYS, PU-PH

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR
  • Elie SALIBA, PU-PH

    CHU de Tours

    PRINCIPAL INVESTIGATOR
  • Gisèle GREMMO-FREGER, PH

    CHU de Brest

    PRINCIPAL INVESTIGATOR
  • Emmanuelle DESCOMBES-BARROSO, PH

    Poitiers University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2012

First Posted

March 16, 2012

Study Start

March 1, 2011

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

August 8, 2016

Record last verified: 2016-08

Locations